IBSF16 2025 – IndieBio – #1 in Early Stage Biotech

Antarka

Dmitry Paperny — Mon, 17 Mar 2025 18:33:54 +0000

Antarka is redefining skincare with next-generation photolyases—specialized enzymes that repair DNA damage caused by UV radiation. Sourced from Antarctic microorganisms, they deliver 100% DNA repair efficacy, offering the best-in-class solution to combat the root cause of skin aging: DNA damage.

Fermeate

Dmitry Paperny — Mon, 17 Mar 2025 18:17:09 +0000

Minutia

Dmitry Paperny — Mon, 17 Mar 2025 18:15:03 +0000

A functional cure for Type I Diabetes which does not require systemic immunosuppressants or an invasive transplant procedure, plus built-in safety monitoring and kill switch functionalities.

Ceal

Dmitry Paperny — Mon, 17 Mar 2025 17:46:32 +0000

Ceal, a carbon dioxide removal (CDR) company, is paving the way for a Net-Zero environment using the most energy-efficient technology ready to scale.
Using its proprietary technology, Ceal’s innovative process utilizes the existing infrastructure of industrial facilities to provide the cheapest gigaton-scale CDR operation. The process is additive- and emission-free, and non-reliant upon the carbon market.
In a highly efficient single-step, Ceal captures and sequesters atmospheric CO2 dissolved in seawater into industry-essential minerals, while providing soft water for various uses. Thus, enabling major cost savings and substantial new revenues for its customers. Ceal’s solution reduces the carbon footprint of the industrial facility, its marine pollution of hazardous chemicals, and simplifies its operation.
Ceal – more than just carbon dioxide removal. We heal the world.

DisperseBio

Dmitry Paperny — Mon, 17 Mar 2025 16:40:50 +0000

Peptide-based solution that disrupts the growth of biofilms by activating the microbe’s natural self biofilm dispersion pathway

Metabolic Psychiatry Labs

Dmitry Paperny — Mon, 17 Mar 2025 16:37:29 +0000

Treating serious mental illness and metabolic sickness through food, real-time data and a remote clinical care team.

SynPlexity

Dmitry Paperny — Mon, 17 Mar 2025 16:27:10 +0000

SynPlexity prints massively parallel amounts of DNA sequences – longer and cheaper than anything else. SynPlexity’s tech will unlock new levels of experimentation and training data for synthetic biology and generative protein AI.

Phytogenesis

Dmitry Paperny — Sun, 16 Mar 2025 01:09:23 +0000

Commercializing newly discovered molecules that induce innate plant defense mechanisms with the goal of greatly reducing, or even eliminating, the need for chemical pesticides, fungicides, and likely insecticides.